VERTEX PHARMACEUTICALS INC / MA Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2010 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 261M shares, a 0.15% increase year-over-year.
  • Vertex Pharmaceuticals Inc / Ma annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 261M shares, a 0.54% increase from 2022.
  • Vertex Pharmaceuticals Inc / Ma annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 259M shares, a 0.31% decline from 2021.
  • Vertex Pharmaceuticals Inc / Ma annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 260M shares, a 1.33% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 261M +400K +0.15% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 258M -2.3M -0.88% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 261M +800K +0.31% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 261M +1.4M +0.54% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 261M +1.1M +0.42% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 260M +1.7M +0.66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 260M +2.4M +0.93% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 259M -800K -0.31% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 260M -200K -0.08% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 259M -2.3M -0.88% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 258M -4M -1.53% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 260M -3.21M -1.22% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 260M -4.38M -1.66% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 261M -2.4M -0.91% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 262M -1.62M -0.61% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 263M +998K +0.38% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-11
Q3 2020 264M +3.61M +1.38% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 263M +3.58M +1.38% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 264M +3.34M +1.28% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 262M +2.3M +0.88% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-11
Q3 2019 260M +685K +0.26% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-11
Q2 2019 260M +1.24M +0.48% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-11
Q1 2019 260M +1.65M +0.64% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-11
Q4 2018 260M +3.01M +1.17% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-13
Q3 2018 260M +9.52M +3.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-13
Q2 2018 259M +6.95M +2.76% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-13
Q1 2018 259M +9.83M +3.95% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-13
Q4 2017 257M +9.05M +3.65% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-13
Q3 2017 250M +5.35M +2.18% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-13
Q2 2017 252M +7.15M +2.93% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-13
Q1 2017 249M +4.87M +2% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-13
Q4 2016 248M +6.45M +2.67% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-15
Q3 2016 245M +2.95M +1.22% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-15
Q2 2016 244M +3.73M +1.55% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-15
Q1 2016 244M +4.34M +1.81% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-15
Q4 2015 241M +6.01M +2.55% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-15
Q3 2015 242M +5.83M +2.47% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-31
Q2 2015 241M +6.95M +2.97% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 239M +6.61M +2.84% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 235M -410K -0.17% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 236M +5.63M +2.44% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 234M +11.8M +5.29% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 233M +17.5M +8.11% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 236M +21.1M +9.84% Oct 1, 2013 Dec 31, 2013 10-K 2014-02-11
Q3 2013 231M +16.7M +7.83% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 222M +10.7M +5.07% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 215M -3.84M -1.75% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 215M -3M -1.38% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-11
Q3 2012 214M -5.58M -2.55% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-11
Q2 2012 211M +6.93M +3.39% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-11
Q1 2012 219M +16.9M +8.37% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-11
Q4 2011 218M +16.2M +8.07% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 219M +18.5M +9.19% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-01
Q2 2011 204M +4.02M +2% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-01
Q1 2011 202M +3.39M +1.71% Jan 1, 2011 Mar 31, 2011 10-K 2013-03-01
Q4 2010 201M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-22
Q3 2010 201M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-22
Q2 2010 200M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-22
Q1 2010 199M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.